...
首页> 外文期刊>Journal of pharmaceutical sciences. >PHARMACEUTICAL NANOTECHNOLOGY Binding of Imipramine, Dosulepin, and Opipramol to Liposomes for Overdose Treatment
【24h】

PHARMACEUTICAL NANOTECHNOLOGY Binding of Imipramine, Dosulepin, and Opipramol to Liposomes for Overdose Treatment

机译:药理学纳米技术将丙咪嗪,多苏平和奥吡莫尔与脂质体结合以进行过量治疗

获取原文
获取原文并翻译 | 示例
           

摘要

Polymer shielded liposomes were investigated as detoxifying agents for the weak bases imipramine and dosulepin and the diprotic drug opipramol. In vitro binding measurements in the presence of human serum samples revealed that the liposomes reduced the free drug concentration of the weak bases (corrected for protein binding) by 88-93%. The reduction for opipramol was around 76%. The results demonstrate that polymer shielded liposomes composed of anionic lipids are widely useful for drug overdose treatment. Polyethylene glycol chain lengths of 2000 and 5000 for the polymer coatings were also explored, and chain length showed no evidence of affecting drug uptake by liposomes. Liposomes compete favorably with other binding targets for drugs, and pharmacokinetic considerations suggest that liposomes could reduce toxicity by transporting drugs from fast-equilibrating organs such as the heart to slow-equilibrating organs such as the fat, muscle, and skin.
机译:研究了聚合物保护的脂质体作为弱碱丙咪嗪和多苏平和双质子药物奥吡莫的排毒剂。在人血清样品存在下的体外结合测量显示,脂质体将弱碱的游离药物浓度(校正为蛋白质结合)降低了88-93%。奥匹拉莫的减少量约为76%。结果表明,由阴离子脂质组成的聚合物屏蔽脂质体可广泛用于药物过量治疗。还研究了聚合物涂层的聚乙二醇链长为2000和5000,并且链长没有显示出影响脂质体吸收药物的证据。脂质体与药物的其他结合靶标竞争良好,并且药代动力学方面的考虑表明,脂质体可以通过将药物从快速平衡的器官(例如心脏)转运到缓慢平衡的器官(例如脂肪,肌肉和皮肤)来降低毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号